S 2476
115th Congress
Senate
Health
Drug safety, medical device, and laboratory regulation
Government information and archives
Intellectual property
Marketing and advertising
Prescription drugs
Expanding Access to Low Cost Generic Drugs Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 28, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 28, 2018
Introduced in Senate
Plain-English summary
Expanding Access to Low Cost Generic Drugs Act
This bill amends the Federal Food, Drug, and Cosmetic Act to disqualify from receiving market exclusivity a generic drug manufacturer who enters into an agreement with the patent holder for a brand name drug to delay getting the generic drug approved or to delay marketing it.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1